INMB
Inmune Bio, Inc.
Company overview
- Market capitalization
- $55.51M
- Employees
- 21
- Latest publication
- 2026-09-29
About Inmune Bio, Inc.
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; GOSH; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 50,000USD | 0USD | 0USD | 38,000USD |
| Cost Of Revenue | 52,000USD | 56,000USD | 28,000USD | — | — | — | — | — |
| Gross Profit | -52,000USD | -56,000USD | -28,000USD | — | 50,000USD | — | — | 38,000USD |
| Research Development | 3,641,000USD | 2,329,000USD | 4,887,000USD | 5,804,000USD | 7,639,000USD | 7,353,000USD | 10,067,000USD | 4,133,000USD |
| Selling General Administrative | 2,171,000USD | 3,145,000USD | 2,546,000USD | 2,198,000USD | 2,316,000USD | 1,953,000USD | 2,219,000USD | 2,285,000USD |
| Total Operating Expenses | 5,760,000USD | 5,418,000USD | 7,433,000USD | 24,571,000USD | 9,955,000USD | 9,467,000USD | 12,286,000USD | 6,461,000USD |
| Operating Income | -5,812,000USD | -5,474,000USD | -7,433,000USD | -24,571,000USD | -9,905,000USD | -9,467,000USD | -12,286,000USD | -6,423,000USD |
| Income Before Tax | -5,407,000USD | -5,264,000USD | -6,472,000USD | -24,458,000USD | -9,739,000USD | -9,218,000USD | -12,093,000USD | -6,536,000USD |
| Net Income | -5,407,000USD | -5,264,000USD | -6,472,000USD | -24,458,000USD | -9,739,000USD | -9,218,000USD | -12,093,000USD | -6,536,000USD |
| Net Income From Continuing Ops | -5,407,000USD | -5,264,000USD | -6,472,000USD | -24,458,000USD | -9,739,000USD | -9,218,000USD | -12,093,000USD | -6,423,000USD |
| Ebit | -5,407,000USD | -5,264,000USD | -6,472,000USD | — | — | -18,934,000USD | — | -12,846,000USD |
| Ebitda | -5,355,000USD | -5,208,000USD | -6,472,000USD | -8,057,000USD | -9,739,000USD | -9,218,000USD | -12,093,000USD | -6,423,000USD |
| Depreciation And Amortization | 52,000USD | 56,000USD | 28,000USD | — | — | 9,467,000USD | — | 6,423,000USD |
| Reconciled Depreciation | 52,000USD | 56,000USD | — | — | 0USD | — | — | — |
| Total Other Income Expense Net | 405,000USD | 210,000USD | 961,000USD | 113,000USD | 166,000USD | 249,000USD | 193,000USD | -113,000USD |
| Selling And Marketing Expenses | — | — | 134,000USD | 55,000USD | — | 41,000USD | 40,000USD | 43,000USD |
| Unclassified Operating Expenses | — | — | — | 16,514,000USD | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | 113,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | 113,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -6,536,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 50,000USD | 14,000USD | 374,000USD | 10,916USD | 0USD | 0USD | 0USD |
| Gross Profit | 50,000USD | 14,000USD | 374,000USD | 10,916USD | 0USD | 0USD | 0USD |
| Research Development | 20,659,000USD | 33,166,000USD | 17,067,000USD | 5,917,495USD | 1,105,389USD | 101,495USD | 101,495USD |
| Selling General Administrative | 10,260,000USD | 9,483,000USD | 9,258,000USD | 6,321,097USD | 11,334,634USD | 125,996USD | 195,472USD |
| Total Operating Expenses | 30,919,000USD | 42,649,000USD | 26,325,000USD | 12,238,592USD | 12,440,023USD | 227,491USD | 48,868USD |
| Operating Income | -30,869,000USD | -42,635,000USD | -25,951,000USD | -12,227,676USD | -12,440,023USD | -227,000USD | -48,868USD |
| Income Before Tax | -45,933,000USD | -42,082,000USD | -27,299,000USD | -12,099,159USD | -12,440,023USD | -277,000USD | -48,868USD |
| Net Income | -45,933,000USD | -42,082,000USD | -28,647,000USD | -12,099,159USD | -12,440,023USD | -277,000USD | -48,868USD |
| Net Income From Continuing Ops | -45,933,000USD | -42,082,000USD | -25,951,000USD | -12,099,159USD | -12,440,023USD | -277,491USD | -195,472USD |
| Ebit | -45,933,000USD | -42,082,000USD | -25,951,000USD | -12,227,676USD | -12,440,023USD | -277,491USD | -48,868USD |
| Ebitda | -45,849,000USD | -41,529,000USD | -27,299,000USD | -12,227,676USD | -12,440,023USD | -50,000USD | 146,604USD |
| Depreciation And Amortization | 84,000USD | 553,000USD | -1,348,000USD | 12,228,000USD | 12,440,023USD | 227,491USD | 195,472USD |
| Reconciled Depreciation | 84,000USD | 0USD | — | — | — | — | — |
| Total Other Income Expense Net | -15,064,000USD | 553,000USD | -1,348,000USD | 128,517USD | 0USD | -50,000USD | 0USD |
| Interest Expense | — | — | 1,348,000USD | 0USD | 0USD | 0USD | 0USD |
| Income Tax Expense | — | — | 1,348,000USD | -128,517USD | -161,141USD | -177,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | -27,299,000USD | -12,099,159USD | -12,440,023USD | -277,491USD | -48,870USD |
| Selling And Marketing Expenses | — | — | — | 52,000USD | — | — | 146,604USD |
| Non Operating Income Net Other | — | — | — | 128,517USD | — | — | — |
| Cost Of Revenue | — | — | — | — | 0USD | 0USD | 0USD |
| Other Operating Expenses | — | — | — | — | — | 227,491USD | 48,868USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 25,818,000USD | 32,351,000USD | 33,358,000USD | 37,684,000USD | 37,801,000USD | 39,562,000USD | 52,782,000USD | 52,453,000USD |
| Other Current Assets | 694,000USD | 595,000USD | 472,000USD | 505,000USD | 207,000USD | 331,000USD | 879,000USD | 1,012,999USD |
| Total Liab | 6,194,000USD | 8,827,000USD | 7,980,000USD | 8,817,000USD | 8,128,000USD | 7,465,000USD | 14,107,000USD | 15,373,000USD |
| Total Stockholder Equity | 19,624,000USD | 23,524,000USD | 25,378,000USD | 28,867,000USD | 29,673,000USD | 32,097,000USD | 38,675,000USD | 37,080,000USD |
| Other Current Liab | 25,000USD | 25,000USD | 25,000USD | 511,000USD | 480,000USD | 517,000USD | 549,000USD | 660,000USD |
| Common Stock | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 23,000USD | 22,000USD | 22,000USD | 819,000USD |
| Capital Stock | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 23,000USD | 22,000USD | 22,000USD | 819,000USD |
| Retained Earnings | -214,444,000USD | -209,037,000USD | -203,773,000USD | -197,301,000USD | -172,843,000USD | -163,104,000USD | -153,886,000USD | -141,793,000USD |
| Cash | 21,358,000USD | 24,751,000USD | 27,734,000USD | 33,374,000USD | 19,337,000USD | 20,922,000USD | 33,552,000USD | 31,069,000USD |
| Cash And Short Term Investments | 21,358,000USD | 24,751,000USD | 27,734,000USD | 33,374,000USD | 19,337,000USD | 20,922,000USD | 33,552,000USD | 31,069,000USD |
| Total Current Assets | 22,822,000USD | 29,887,000USD | 30,670,000USD | 36,034,000USD | 20,960,000USD | 22,662,000USD | 35,851,000USD | 35,495,000USD |
| Total Current Liabilities | 5,388,000USD | 8,416,000USD | 7,357,000USD | 8,586,000USD | 7,927,000USD | 7,221,000USD | 13,823,000USD | 15,051,000USD |
| Net Debt | -19,848,000USD | -23,717,000USD | -26,654,000USD | -32,923,000USD | -18,990,000USD | -20,538,000USD | -30,639,000USD | -25,638,000USD |
| Short Term Debt | 704,000USD | 623,000USD | 457,000USD | 220,000USD | 146,000USD | 140,000USD | 2,629,000USD | 5,109,000USD |
| Short Long Term Debt Total | 1,510,000USD | 1,034,000USD | 1,080,000USD | 451,000USD | 347,000USD | 384,000USD | 2,913,000USD | 5,431,000USD |
| Net Receivables | 770,000USD | 4,541,000USD | 2,464,000USD | 2,155,000USD | 1,416,000USD | 1,409,000USD | 1,420,000USD | 3,413,000USD |
| Accounts Payable | 4,659,000USD | 7,768,000USD | 6,875,000USD | 7,855,000USD | 7,301,000USD | 6,564,000USD | 10,645,000USD | 9,282,000USD |
| Property Plant Equipment Net | 2,313,000USD | 914,000USD | 1,064,000USD | 1,080,000USD | 278,000USD | 307,000USD | 335,000USD | 363,000USD |
| Property Plant Equipment Gross | 2,313,000USD | 1,869,000USD | 1,942,000USD | 1,080,000USD | 278,000USD | 307,000USD | 335,000USD | 363,000USD |
| Accumulated Other Comprehensive Income | -727,000USD | -737,000USD | -764,000USD | -763,000USD | -610,000USD | -575,000USD | -1,036,000USD | -713,000USD |
| Common Stock Shares Outstanding | 26,585,258shares | 26,585,258shares | 26,585,258shares | 23,298,455shares | 22,496,000shares | 22,280,000shares | 20,186,000shares | 19,307,000shares |
| Non Current Assets Total | 2,996,000USD | 2,464,000USD | 2,688,000USD | 1,650,000USD | 16,841,000USD | 16,900,000USD | 16,931,000USD | 16,958,000USD |
| Non Current Liabilities Total | 806,000USD | 411,000USD | 623,000USD | 231,000USD | 201,000USD | 244,000USD | 284,000USD | 322,000USD |
| Non Currrent Assets Other | 683,000USD | 1,550,000USD | 1,624,000USD | 570,000USD | 49,000USD | 79,000USD | 82,000USD | 81,000USD |
| Net Working Capital | 17,434,000USD | 21,471,000USD | 23,313,000USD | 27,448,000USD | 13,033,000USD | 15,441,000USD | 22,028,000USD | 20,444,000USD |
| Unclassified Equity | 234,741,000USD | 233,244,000USD | 229,861,000USD | 226,877,000USD | 203,080,000USD | 195,732,000USD | 193,553,000USD | 177,948,000USD |
| Current Deferred Revenue | — | — | — | 511,000USD | 480,000USD | — | 549,000USD | 521,000USD |
| Intangible Assets | — | — | — | — | 16,514,000USD | 16,514,000USD | 16,514,000USD | 16,514,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 2,494,000USD | 4,979,000USD |
| Inventory | — | — | — | — | — | — | -1,420,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -3,043,000USD | -5,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 32,351,000USD | 39,562,000USD | 57,001,000USD | 81,795,000USD | 99,945,000USD | 40,656,000USD | 24,470,321USD | 17,363,342USD |
| Other Current Assets | 595,000USD | 331,000USD | 1,652,000USD | 4,027,000USD | 7,796,000USD | 2,019,000USD | 769,253,000USD | 15,552USD |
| Total Liab | 8,827,000USD | 7,465,000USD | 18,862,000USD | 21,691,000USD | 19,720,000USD | 1,902,000USD | 860,543USD | 823,766USD |
| Total Stockholder Equity | 23,524,000USD | 32,097,000USD | 38,139,000USD | 60,104,000USD | 80,225,000USD | 38,754,000USD | 23,609,778USD | 16,539,576USD |
| Other Current Liab | 25,000USD | 517,000USD | 524,000USD | 9,000USD | -62,000USD | 224,000USD | 588,492USD | 270,545USD |
| Common Stock | 27,000USD | 22,000USD | 817,000USD | 18,000USD | 18,000USD | 13,000USD | 10,771USD | 8,719USD |
| Capital Stock | 27,000USD | 22,000USD | 817,000USD | 18,000USD | 18,000USD | 13,481USD | 10,771USD | 8,719USD |
| Retained Earnings | -209,037,000USD | -163,104,000USD | -121,022,000USD | -91,014,000USD | -63,715,000USD | -33,375,000USD | -21,276,181USD | -13,597,868USD |
| Cash | 24,751,000USD | 20,922,000USD | 35,848,000USD | 52,153,000USD | 74,810,000USD | 21,967,000USD | 6,995,525USD | 186,204USD |
| Cash And Short Term Investments | 24,751,000USD | 20,922,000USD | 35,848,000USD | 52,153,000USD | 74,810,000USD | 21,967,000USD | 6,995,525USD | 186,204USD |
| Total Current Assets | 29,887,000USD | 22,662,000USD | 39,942,000USD | 64,675,000USD | 82,606,000USD | 23,986,000USD | 7,764,778USD | 849,342USD |
| Total Current Liabilities | 8,416,000USD | 7,221,000USD | 18,465,000USD | 10,918,000USD | 4,359,000USD | 1,776,000USD | 700,379USD | 823,766USD |
| Net Debt | -23,717,000USD | -20,538,000USD | -25,411,000USD | -36,843,000USD | -59,576,000USD | -21,807,000USD | -6,827,073USD | -186,204USD |
| Short Term Debt | 623,000USD | 140,000USD | 10,040,000USD | 5,087,000USD | 144,000USD | 34,000USD | 8,288USD | — |
| Short Long Term Debt Total | 1,034,000USD | 384,000USD | 10,437,000USD | 15,310,000USD | 15,234,000USD | 160,000USD | 168,452USD | — |
| Net Receivables | 4,541,000USD | 1,409,000USD | 2,442,000USD | 8,461,000USD | 5,504,000USD | 1,799,000USD | 645,364USD | 647,586USD |
| Accounts Payable | 7,768,000USD | 6,564,000USD | 7,901,000USD | 5,206,000USD | 3,803,000USD | 1,518,000USD | 401,989USD | 553,221USD |
| Property Plant Equipment Net | 914,000USD | 307,000USD | 414,000USD | 507,000USD | 726,000USD | 156,000USD | 191,543USD | — |
| Property Plant Equipment Gross | 1,869,000USD | 307,000USD | 414,000USD | 507,000USD | 726,000USD | 156,214USD | 191,543USD | — |
| Accumulated Other Comprehensive Income | -737,000USD | -575,000USD | -799,000USD | -699,000USD | 1,000USD | 10,999USD | -8,515USD | 6,529USD |
| Common Stock Shares Outstanding | 26,585,258shares | 19,944,000shares | 17,981,000shares | 17,927,000shares | 16,131,000shares | 11,988,000shares | 10,273,000shares | 11,219,000shares |
| Non Current Assets Total | 2,464,000USD | 16,900,000USD | 17,059,000USD | 17,120,000USD | 17,339,000USD | 16,670,000USD | 16,705,543USD | 16,514,000USD |
| Non Current Liabilities Total | 411,000USD | 244,000USD | 397,000USD | 10,773,000USD | 15,361,000USD | 126,000USD | 160,164USD | 0USD |
| Non Currrent Assets Other | 1,550,000USD | 79,000USD | 131,000USD | 99,000USD | 99,000USD | 99,000USD | -16,705,543USD | 16,514,000USD |
| Net Working Capital | 21,471,000USD | 15,441,000USD | 21,477,000USD | 53,757,000USD | 78,247,000USD | 22,209,460USD | 7,064,399USD | 25,576USD |
| Unclassified Equity | 233,244,000USD | 195,732,000USD | 158,326,000USD | 151,781,000USD | 143,903,000USD | 72,091,520USD | 44,872,932USD | 30,113,477USD |
| Intangible Assets | — | 16,514,000USD | 16,514,000USD | 16,514,000USD | 16,514,000USD | 16,514,000USD | 16,514,000USD | 16,514,000USD |
| Other Assets | — | — | 1USD | 99,000USD | 99,000USD | 156,214USD | — | — |
| Current Deferred Revenue | — | — | 489,000USD | 616,000USD | 474,000USD | 190,612USD | -298,390USD | — |
| Short Long Term Debt | — | — | 9,921,000USD | 5,000,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | -10,410,000USD | -5,000,000USD | — | — | — | — |
| Other Liab | — | — | — | 550,000USD | 199,000USD | — | — | — |
| Long Term Debt | — | — | — | 9,697,000USD | 14,458,000USD | — | — | — |
| Inventory | — | — | — | 34,000USD | -5,504,000USD | -2,018,618,910USD | -769,129,111USD | — |
| Non Current Liabilities Other | — | — | — | 1,076,000USD | 903,000USD | 126,286USD | 160,164USD | — |
| Net Tangible Assets | — | — | — | 43,590,000USD | 63,711,000USD | 22,239,388USD | 7,095,778USD | 25,576USD |
| Unclassified Current Assets | — | — | — | — | -5,504,000USD | -1,799,000USD | -769,129,111USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | -16,514,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,407,000USD | -6,472,000USD | -24,458,000USD | -9,739,000USD | -9,218,000USD | -12,093,000USD | -9,746,000USD | -11,025,000USD |
| Depreciation | 52,000USD | 28,000USD | — | 0USD | — | -24,000USD | 24,000USD | 34,000USD |
| Stock Based Compensation | 1,497,000USD | 2,984,000USD | 1,534,000USD | 2,076,000USD | 1,757,000USD | 1,719,000USD | 2,350,000USD | 1,779,000USD |
| Other Non Cash Items | -91,000USD | -598,000USD | 16,514,000USD | — | 6,000USD | 39,000USD | 24,000USD | 34,000USD |
| Change To Account Receivables | 3,771,000USD | -309,000USD | -739,000USD | -7,000USD | 11,000USD | 1,993,000USD | -723,000USD | -248,000USD |
| Change In Working Capital | 546,000USD | -1,353,000USD | -965,000USD | 839,000USD | -3,558,000USD | 3,373,000USD | -514,000USD | 1,736,000USD |
| Total Cash From Operating Activities | -3,403,000USD | -5,439,000USD | -7,375,000USD | -6,824,000USD | -11,013,000USD | -6,986,000USD | -7,886,000USD | -7,476,000USD |
| Capital Expenditures | 0USD | -193,000USD | -705,999USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,403,000USD | -5,632,000USD | -8,080,999USD | -6,824,000USD | -11,013,000USD | -6,986,000USD | -7,886,000USD | -7,476,000USD |
| Total Cash From Financing Activities | 0USD | 0USD | 22,271,000USD | 5,274,000USD | -2,078,000USD | 9,792,000USD | 12,997,000USD | -2,500,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 22,271,000USD | 5,273,000USD | 0USD | 12,292,000USD | 15,497,000USD | 0USD |
| Change In Cash | -3,393,000USD | -5,640,000USD | 14,037,000USD | -1,585,000USD | -12,630,000USD | 2,483,000USD | 5,067,000USD | -9,846,000USD |
| Begin Period Cash Flow | 24,751,000USD | 33,374,000USD | 19,337,000USD | 20,922,000USD | 33,552,000USD | 31,069,000USD | 26,002,000USD | 35,848,000USD |
| End Period Cash Flow | 21,358,000USD | 27,734,000USD | 33,374,000USD | 19,337,000USD | 20,922,000USD | 33,552,000USD | 31,069,000USD | 26,002,000USD |
| Investments | — | -193,000USD | — | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | -193,000USD | -706,000USD | — | — | — | — | — |
| Net Borrowings | — | 0USD | 0USD | 0USD | -2,500,000USD | -2,500,000USD | — | — |
| Other Cashflows From Investing Activities | — | -899,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | 1,092,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | — | — | 1,000USD | 422,000USD | 2,500,000USD | 15,497,000USD | -2,500,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -2,500,000USD | -17,997,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,933,000USD | -42,082,000USD | -30,008,000USD | -30,340,000USD | -12,099,159USD | -7,678,313USD | -12,440,023USD | -831,486USD |
| Depreciation | 84,000USD | 0USD | 224,000USD | 126,000USD | — | — | — | — |
| Stock Based Compensation | 9,910,000USD | 7,605,000USD | 7,368,000USD | 4,796,000USD | 3,112,000USD | 4,096,538USD | 10,001,359USD | 199,556USD |
| Other Non Cash Items | 15,888,000USD | 79,000USD | 224,000USD | 126,000USD | 3,112,004USD | -1,542,000USD | 9,807,288USD | -150,000USD |
| Change To Account Receivables | -3,132,000USD | 1,033,000USD | 6,019,000USD | -3,705,000USD | -1,153,385USD | 2,222USD | -319,978USD | -67,122USD |
| Change In Working Capital | -2,531,000USD | 1,037,000USD | 10,436,000USD | -3,086,000USD | 43,509USD | -260,881USD | 379,670USD | 20,096USD |
| Total Cash From Operating Activities | -22,582,000USD | -33,361,000USD | -11,980,000USD | -28,504,000USD | -8,943,646USD | -5,384,656USD | -2,058,994USD | -761,834USD |
| Capital Expenditures | -1,042,000USD | 0USD | 0USD | -15,000,000USD | -4USD | 0USD | 0USD | -100,000USD |
| Free Cash Flow | -23,624,000USD | -33,361,000USD | -11,980,000USD | -43,504,000USD | -8,943,650USD | -5,384,656USD | -2,058,994USD | -861,834USD |
| Total Cashflows From Investing Activities | -1,042,000USD | — | — | -15,000,000USD | -15,000,000USD | -15,000,000USD | -15,000,000USD | -100,000USD |
| Net Borrowings | 0USD | -10,000,000USD | -5,000,000USD | 14,951,000USD | 14,951,000USD | 14,951,000USD | 14,951,000USD | — |
| Total Cash From Financing Activities | 27,612,000USD | 18,211,000USD | -4,225,000USD | 96,357,000USD | 23,895,781USD | 12,209,021USD | 900,000USD | 2,056,000USD |
| Issuance Of Capital Stock | 27,544,000USD | 27,789,000USD | 775,000USD | 80,253,000USD | 24,907,781USD | 12,209,021USD | 900,000USD | — |
| Change In Cash | 3,829,000USD | -14,926,000USD | -16,305,000USD | 52,843,000USD | 14,971,358USD | 6,809,321USD | -1,184,507USD | 1,229,052USD |
| Begin Period Cash Flow | 20,922,000USD | 35,848,000USD | 52,153,000USD | 21,967,000USD | 6,995,525USD | 186,204USD | 1,370,711USD | 141,659USD |
| End Period Cash Flow | 24,751,000USD | 20,922,000USD | 35,848,000USD | 74,810,000USD | 21,966,883USD | 6,995,525USD | 186,204USD | 1,370,711USD |
| Other Cashflows From Investing Activities | -1,042,000USD | — | — | -15,000,000USD | -15,000,000USD | -15,000,000USD | -15,000,000USD | -100,000USD |
| Other Cashflows From Financing Activities | 27,612,000USD | 422,000USD | 775,000USD | 1,153,000USD | 24,907,000USD | 12,209,021USD | — | -100,000USD |
| Unclassified Investing Cash Flow | 1,042,000USD | — | — | 30,000,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | -27,544,000USD | — | — | -1,153,000USD | -14,950,219USD | -27,160,021USD | -14,951,000USD | — |
| Change To Inventory | — | — | — | 3,705,000USD | 1,153,385USD | -2,222USD | — | — |
| Change To Liabilities | — | — | — | 2,460,000USD | 1,075,447USD | -131,675USD | 514,049USD | 238,907USD |
| Investments | — | — | — | -15,000,000USD | 0USD | — | 0USD | -100,000USD |
| Sale Purchase Of Stock | — | — | — | 81,406,000USD | -1,012,000USD | 12,209,021USD | 900,000USD | 2,056,000USD |
| Exchange Rate Changes | — | — | — | -10,000USD | 19,223USD | -15,044USD | -25,513USD | — |
| Cash And Cash Equivalents Changes | — | — | — | 52,843,000USD | 14,971,358USD | 6,809,321USD | -1,184,507USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | -3,112,000USD | — | -9,807,288USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.